Chemcon Speciality Chemicals reported a 72% year-on-year rise in net profit to ₹10.96 crore for the quarter ended June 30, 2026 (Q1FY27), driven by improved realizations across its product portfolio and a sharp expansion in operating margins. Revenue from operations grew 24.2% to ₹66.49 crore, while EBITDA more than doubled to ₹15.40 crore, pushing the EBITDA margin to 23.31% from 14.52% in the corresponding period of FY26. The performance underscores robust demand in the specialty chemicals segment, particularly in organic chemicals, despite persistent pricing pressure from global competition.

The Board of Directors approved the unaudited financial results at a meeting held on August 3, 2026. The results were reviewed by statutory auditors Shah Mehta & Bakshi pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In an accompanying investor presentation released on August 4, 2026, management attributed the strong start to FY27 to better absorption of fixed costs and favorable market conditions in key product categories such as HMDS, CMIC, Bromobenzene, and 2-Bromo.

Financial Performance

Revenue growth was supported by higher volumes and improved pricing, although total sales volume declined slightly to 2,066 MT from 2,098 MT in Q1FY26, reflecting a shift towards higher-value products. The Organic Chemicals segment contributed 75% of revenue, up from 79% in Q1FY26 but down from 71% in Q4FY26. Other income remained stable at ₹3.72 crore. Total expenses rose 14.0% to ₹55.66 crore, primarily due to higher material costs which increased to ₹42.27 crore from ₹28.80 crore. Despite this, profit before tax expanded to ₹14.55 crore from ₹8.43 crore.

Earnings per share (basic) rose to ₹2.99 from ₹1.74. For the full year FY26, the company reported a net profit of ₹23.60 crore on revenue of ₹240.00 crore.

Segment and Operational Insights

The Organic Chemicals business witnessed notable improvement, driven by HMDS, where Chemcon is the only manufacturer in India and the third-largest globally. The Inorganic Chemicals segment, comprising bromides like Calcium Bromide and Zinc Bromide, also recorded stable performance aided by improved demand. Geographically, domestic sales accounted for 69% of revenue in Q1FY27, compared to 70% in Q1FY26, while exports stood at 31%. The company maintains two manufacturing facilities in Vadodara, Gujarat, with an installed capacity of 11,400 MTPA for organic chemicals and 15,000 MTPA for inorganic chemicals.

What the Numbers Show

A key analytical observation is the significant operating leverage demonstrated in Q1FY27. While revenue grew by 24.2%, total expenses increased by only 14.0%, leading to an EBITDA margin expansion of approximately 879 basis points. This divergence suggests that the company successfully passed on material cost increases to customers or optimized its product mix towards higher-margin items. The stability in other income and moderate increase in employee benefits further indicate that the profit expansion was primarily operational, stemming from improved realizations and efficiency gains rather than one-off gains.

Compliance and Disclosures

The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013. The company operates in a single reportable segment as per Ind AS 108 - Operating Segments. It confirmed that it has no subsidiary, associate, or joint venture company as of June 30, 2026. The investor presentation was filed pursuant to Regulation 30 of the SEBI LODR Regulations, 2015.

Chemcon Speciality Chemicals reported a net profit of ₹1,096.29 lakh for the quarter ended June 30, 2026, up from ₹638.71 lakh in the same period of FY25. The speciality chemicals manufacturer saw its revenue from operations grow by 22.7% year-on-year to ₹7,021.06 lakh, reflecting robust demand across its product portfolio. This performance underscores the company’s ability to scale profitability amid operational efficiencies.

The results were published on August 4, 2026, in Loksatta Jansatta and Business Standard, and filed with the Bombay Stock Exchange and National Stock Exchange of India Limited under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The unaudited financials were signed off by Chairman & Managing Director Kamalkumar Rajendra Aggarwal.

Financial Performance Highlights

Chemcon Speciality Chemicals delivered strong top-line and bottom-line growth in Q1FY26 compared to the previous fiscal year. The company’s net profit before tax stood at ₹1,455.18 lakh, a substantial improvement over ₹843.03 lakh recorded in Q1FY25. Earnings per share (basic) rose to ₹2.99 from ₹1.74 in the prior year’s first quarter.

On a quarterly basis, revenue declined slightly to ₹7,021.06 lakh from ₹7,957.72 lakh in Q4FY26. However, net profit after tax increased to ₹1,096.29 lakh from ₹637.13 lakh in the preceding quarter, indicating improved margin dynamics or cost controls in the current period.

What the Numbers Show

The divergence between quarterly revenue contraction and profit expansion suggests that Chemcon Speciality Chemicals benefited from favorable product mix shifts or reduced input costs in Q1FY26. While total income dipped nearly 12% sequentially, the net profit after tax surged approximately 72% quarter-on-quarter. This indicates that the company’s core operations became more efficient, allowing it to retain a higher proportion of earnings despite lower sales volumes compared to the previous quarter. The consistent equity share capital of ₹3,663.07 lakh further stabilizes the earnings per share calculation, ensuring the profit growth directly translates to shareholder value.